Ignite Creation Date:
2024-05-06 @ 1:13 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03969121
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2019-05-13
Brief Title:
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable Hormone Sensitive and HER2-Negative Primary Breast Cancer
Sponsor:
Kyoto Breast Cancer Research Network
Organization:
Kyoto Breast Cancer Research Network